Highlights
A collection of news and information related to Gilead Sciences Inc. published by this site and its partners.
Displaying items 1-12 of 22
» View wsbtradio.com items only
1
2
•
Next >
-
U.S. RESEARCH ROUNDUP: Visa, Wal-Mart, Biogen Idec, Walt Disney
ReutersMay 17 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S. companies, including Macy's and Biogen Idec on Friday. HIGHLIGHTS * Aruba Networks : FBN, JP Morgan, Needham, Wedbush, Wells Fargo cut rating *...Tags: Triumph Group Inc., Williams-Sonoma Inc., ViaSat Incorporated, Beazer Homes USA Incorporated, Crown Castle International Corporation
-
Experimental Gilead drug effective in early-stage leukemia trial
ReutersBy Deena Beasley May 15 (Reuters) - An experimental drug from Gilead Sciences Inc shrank tumors in half of leukemia patients whose cancer had returned, according to an early-stage trial that represents a new foray into oncology by the world's biggest...Tags: Ice Hockey, Trials, Hodgkin's Lymphoma, Medical Specialization, National Hockey League
-
U.S. RESEARCH ROUNDUP: AIG, Express Scripts, Eli Lilly, Carlyle Group
ReutersMay 13 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S. companies, including AIG, Carlyle Group and Express Scripts, on Monday. HIGHLIGHTS * AIG : Barclays raises to overweight from equal weight -...Tags: Morgan Stanley Dean Witter & Company, Golf, MGM Resorts International, Lilly Eli & Co, Johnson Controls Incorporated
-
Many in U.S. don't get proper testing for hepatitis C- CDC
ReutersBy Julie Steenhuysen NEW YORK, May 8 (Reuters) - Only half of people in the United States who have ever been infected with hepatitis C get proper testing for the liver-destroying disease, according to U.S. health officials. Proper testing is a two-...Tags: U.S. Centers for Disease Control and Prevention, Medical Procedures and Tests, Liver Cancer, Disease Prevention, Medical Research
-
REUTERS SUMMIT-Biotech firms evolve from targets to acquirers
Reuters(For other news from Reuters Health Summit, click on http://www.reuters.com/summit/Health13) * Skyrocketing valuations quash talks * With financing available, many biotechs go it alone * Bankers expect steady flow of $1 bln to $5 bln pharma deals By...Tags: Mergers, Acquisitions and Takeovers, Science and Technology, Macular Degeneration, Biotechnology Industry, Hepatitis C
-
U.S. RESEARCH ROUNDUP: Estee Lauder, Actavis, MGM Resorts
ReutersMay 3 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S. companies, including Estee Lauder and MGM Resorts, on Friday. HIGHLIGHTS * LinkedIn Corp : BMO, JP Morgan, Canaccord Genuity, others raise...Tags: Triumph Group Inc., MGM Resorts International, Essex Property Trust Inc., Harris Teeter, Inc., Natural Resource Industry
-
CORRECTED-Gilead profit rises 63 pct, sales of older HIV drugs dip
Reuters(Corrects 3rd paragraph to show Complera sales rose 184 percent, not 10 percent; shows that sales of Stribild totaled $92.1 million, with no prior year comparison, not that they rose 184 percent) May 2 (Reuters) - Gilead Sciences Inc said on Thursday its...Tags: Earnings Forecasts, Thomson Corporation, HIV, New Products, Truvada
-
U.S. RESEARCH ROUNDUP: MasterCard, Visa, Facebook, Las Vegas Sands
ReutersMay 2 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S. companies, including Visa and Facebook, on Thursday. HIGHLIGHTS * MasterCard Inc : Nomura cuts target price to $593 from $611; rating buy * DXP...Tags: Yelp, Inc., CVS Corp., Jack Henry & Associates Incorporated, Newmont Mining Corporation, Brookdale Senior Living Incorporated
-
US STOCKS SNAPSHOT-Nasdaq up 1 pct as Wall St extends advance
ReutersNEW YORK, May 2 (Reuters) - U.S. stocks extended their advance on Thursday, with the Nasdaq Composite up 1 percent, led by gains in shares of Apple and Gilead Sciences. The Dow Jones industrial average rose 113.46 points or 0.77 percent, to 14,814.41,...Tags: Nasdaq Composite, NASDAQ, Money and Monetary Policy, Financial Markets, Stock Activities
-
U.S. RESEARCH ROUNDUP: 3M, Time Warner, Walt Disney, Caterpillar
ReutersApril 29 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S. companies, including Time Warner, 3M Co and Caterpillar, on Monday. HIGHLIGHTS * 3M Co : JP Morgan cuts target price to $95 from $97; rating...Tags: Gold and Precious Material, Oriental Financial Group Incorporated, DTE Energy Company, Range Resources Corporation, Principal Financial Group Incorporated
-
AbbVie says drug cocktail wipes out hepatitis C in 8 weeks
ReutersAbbVie Inc. said tests show its five-drug cocktail known as Aviator wipes out the hepatitis C virus in 96 percent of patients who take it for 12 weeks -- less than half the time of current treatments, according to researchers. At least 88 percent of new...Tags: NYSE Euronext, Inc., Liver Cancer, Trials, Insomnia, Science and Technology
-
Bristol-Myers oral hepatitis C regimen looks competitive -study
Reuters* 94 pct cure rate seen with Bristol-Myers oral regimen * Three-drug regimen does not include ribavirin * 2 serious side effects likely unconnected to Bristol drugs By Bill Berkrot April 23 (Reuters) - A combination of three experimental Bristol-Myers...Tags: Liver Cancer, Trials, Liver Disease, Medical Research, Hepatitis C
May 17, 2013
|Story| Reuters
May 15, 2013
|Story| Reuters
May 13, 2013
|Story| Reuters
May 8, 2013
|Story| Reuters
May 7, 2013
|Story| Reuters
May 3, 2013
|Story| Reuters
May 2, 2013
|Story| Reuters
May 2, 2013
|Story| Reuters
May 2, 2013
|Story| Reuters
Apr 29, 2013
|Story| Reuters
Apr 23, 2013
|Story| Reuters
Apr 23, 2013
|Story| Reuters
Original site for Gilead Sciences Inc. topic gallery.